시장보고서
상품코드
2130673

양자점 바이오센서 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 구성 요소, 용도, 재료 유형, 최종 사용자, 기능, 설치 형태, 모드

Quantum Dot Biosensors Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Material Type, End User, Functionality, Installation Type, Mode

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,445,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 7,802,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,159,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 양자점 바이오센서 시장은 2025년 4억 달러에서 2035년까지 31억 달러로 성장하여 CAGR은 22.7%를 나타낼 것으로 예측됩니다. 양자점 바이오센서 시장은 고감도 바이오마커 검출, 신속 진단 및 소형화된 센싱 기술에 대한 수요에 힘입어 성장하고 있습니다. 2025년 7월, 미국 국립의학도서관(NLM)이 색인화한 연구에서는 조정 가능한 광학적 및 전자적 특성을 활용하여 단백질, 핵산 및 기타 생체 분자를 검출하는 양자점 바이오센서가 주목을 받았습니다. 형광 양자점, 탄소 양자점, 전기화학 센싱, 다중 검출 및 스마트폰 통합 플랫폼 분야의 기술 발전으로 인해 암 진단, 감염병 검사 및 현장 진료(Point-of-Care) 의료 분야의 응용 범위가 확대되고 있습니다.

양자점 바이오센서 시장의 유형별 부문에는 형광형, 전기화학형, 비색형 및 기타가 포함됩니다. 2025년에는 양자점의 우수한 광학적 특성, 높은 감도 및 저농도 생물학적 표적 검출에 대한 적합성을 배경으로 형광형이 가장 큰 점유율을 차지했습니다. 전기화학형은 현장 진단 및 실시간 모니터링을 위한 소형, 고감도, 휴대 가능한 바이오센싱 플랫폼에 대한 수요에 힘입어 가장 빠르게 성장하는 부문이 될 것으로 예측됩니다. 비색법 및 기타는 특수한 검출 및 분석 용도를 뒷받침하고 있습니다.

양자점 바이오센서 시장의 최종 사용자 부문에는 병원, 연구소, 제약 회사, 생명공학 기업, 기타가 포함됩니다. 2025년에는 질병 감지, 임상 진단, 환자 모니터링을 위한 첨단 바이오센서의 채택 확대에 힘입어 병원이 가장 큰 점유율을 차지했습니다. 생명공학 기업은 바이오마커 검출, 분자 분석, 연구 분야에서 양자점 바이오센서의 응용 확대에 힘입어 가장 빠르게 성장하는 부문이 될 것으로 예측됩니다. 연구소는 바이오센서 개발을 지원하고 있는 반면, 제약 회사는 신약 개발 및 시험에 이러한 기술을 활용하고 있습니다.

지역별 개요

2025년, 북미는 양자점 바이오센서 시장에서 주도적인 지역이 되었습니다. 이는 선진적인 의료 인프라, 강력한 생명공학 및 제약 연구, 그리고 고감도 진단 기술의 조기 도입에 힘입은 결과입니다. 이 지역은 나노 소재, 분자진단, 현장 진단(Point-of-Care) 검사, 그리고 광학 바이오센싱에 관한 광범위한 조사의 혜택을 받았습니다. 또한, 전문 바이오센서 개발 기업의 존재와 확립된 임상 검사 네트워크 역시 양자점 기반 검출 플랫폼의 상용화를 뒷받침했습니다. 암 진단, 감염병, 맞춤형 의료 등의 분야에서 신속하고 고감도 바이오마커 검출에 대한 수요가 증가함에 따라 도입이 더욱 가속화되었습니다. 대학, 의료 기관, 기술 개발 기업 간의 강력한 연구 협력은 양자점 바이오센싱의 혁신을 지속적으로 뒷받침했습니다.

아시아태평양은 의료 인프라 확충, 생명공학에 대한 투자 증가, 그리고 첨단 진단 기술에 대한 수요 증가에 힘입어, 예측 기간 동안 양자점 바이오센서 시장에서 가장 빠른 성장을 이룰 지역이 될 것으로 예측됩니다. 중국, 일본, 한국, 인도는 나노기술, 바이오센서, 분자진단, 현장 진단(POC) 분야의 연구 증가를 통해 시장에 크게 기여할 것으로 전망됩니다. 의료비 증가와 만성 질환 및 감염병의 신속한 검출에 대한 수요 증가가 고감도 바이오센싱 플랫폼 시장 기회를 창출하고 있습니다. 또한, 양자점 기술은 식품 안전 및 환경 모니터링 분야에서도 활용 방안이 모색되고 있어 그 응용 범위가 확대되고 있습니다. 연구 개발 역량의 확대와 현지 기술 개발을 통해 해당 지역 전체에서의 도입이 더욱 가속화될 것으로 예측됩니다.

주요 동향 및 성장 촉진요인

다중 형광 및 근적외선 검출 :

양자점 바이오센서 시장의 주요 동향 중 하나는 여러 바이오마커를 동시에 검출할 수 있는 다중 형광 및 근적외선 센싱 플랫폼의 개발입니다. 양자점은 발광 파장의 조절 가능성, 높은 광안정성 및 강한 형광성을 갖추고 있어, 동일한 분석 내에서 서로 다른 양자점을 서로 다른 생물학적 표적에 할당할 수 있습니다. 근적외선 양자점 또한 생물학적 응용 분야에서 조직의 자가형광을 감소시키고 영상 깊이를 향상시킬 수 있어 주목받고 있습니다. 최근 연구에서는 단백질, 핵산, 병원체 및 암 바이오마커를 동시에 검출하는 양자점(QD) 기반 플랫폼이 주목받고 있으며, 이를 통해 보다 종합적인 질병 프로파일링과 실시간 분자 분석이 가능해졌습니다.

고감도 질환 조기 검진에 대한 수요 :

양자점 바이오센서 시장의 주요 성장 동인 중 하나는 질환의 초기 단계에서 저농도의 바이오마커를 검출해야 할 필요성입니다. 기존의 진단법은 특히 질환 진행 초기 단계에서 바이오마커 농도가 극히 낮은 경우 한계에 부딪힐 수 있습니다. 양자점은 높은 양자 수율, 조절 가능한 광학적 특성, 그리고 뛰어난 광안정성을 갖추고 있어 단백질, 핵산, 대사산물 및 암 관련 바이오마커의 고감도 검출을 가능하게 합니다. 연구를 통해 QD를 활용한 센싱 플랫폼을 이용한 극히 낮은 검출 한계가 입증되었으며, 항체, 어프타머,펩타이드 및 핵산에 의한 표면 기능화를 통해 표적에 대한 특이성이 향상됩니다. 이러한 기능 덕분에 더 높은 감도로 다항목 동시 측정이 가능하며, 신속한 진단 기술의 개발이 촉진되고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문별 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 회사 소개

KTH 26.09.28

The global Quantum Dot Biosensors Market is projected to grow from $0.4 billion in 2025 to $3.1 billion by 2035, at a compound annual growth rate (CAGR) of 22.7%. The Quantum Dot Biosensors Market is driven by demand for highly sensitive biomarker detection, rapid diagnostics, and miniaturized sensing technologies. In July 2025, research indexed by the U.S. National Library of Medicine (NLM) highlighted quantum-dot biosensors for detecting proteins, nucleic acids, and other biomolecules using their tunable optical and electronic properties. Advances in fluorescent quantum dots, carbon quantum dots, electrochemical sensing, multiplex detection, and smartphone-integrated platforms are expanding applications in cancer diagnostics, infectious-disease testing, and point-of-care healthcare.

The Type segment of the Quantum Dot Biosensors Market includes Fluorescent, Electrochemical, Colorimetric, and Others. Fluorescent held the largest share in 2025, supported by the strong optical properties of quantum dots, high sensitivity, and suitability for detecting low concentrations of biological targets. Electrochemical is expected to be the fastest-growing segment, driven by demand for compact, sensitive, and portable biosensing platforms for point-of-care diagnostics and real-time monitoring. Colorimetric and Others support specialized detection and analytical applications.

Market Segmentation
TypeFluorescent, Electrochemical, Colorimetric, Others
ProductIn-Vitro Diagnostics, Point-of-Care Testing Devices, Wearable Biosensors, Others
TechnologyQuantum Dot Conjugation, Surface Modification, Signal Amplification, Others
ComponentQuantum Dot Core, Surface Coating, Biorecognition Elements, Transducer, Others
ApplicationMedical Diagnostics, Environmental Monitoring, Food Safety Testing, Drug Discovery, Others
Material TypeCadmium-Based Quantum Dots, Cadmium-Free Quantum Dots, Carbon Quantum Dots, Others
End UserHospitals, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Others
FunctionalityDetection, Quantification, Monitoring, Others
Installation TypePortable, Benchtop, Wearable, Others
ModeSingle-Use, Reusable, Others

The End User segment of the Quantum Dot Biosensors Market includes Hospitals, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, and Others. Hospitals held the largest share in 2025, driven by increasing adoption of advanced biosensors for disease detection, clinical diagnostics, and patient monitoring. Biotechnology Firms are expected to be the fastest-growing segment, supported by expanding applications of quantum dot biosensors in biomarker detection, molecular analysis, and research. Research Laboratories support biosensor development, while Pharmaceutical Companies use these technologies for drug discovery and testing.

Geographical Overview

North America was the leading region in the Quantum Dot Biosensors Market in 2025, supported by advanced healthcare infrastructure, strong biotechnology and pharmaceutical research, and early adoption of high-sensitivity diagnostic technologies. The region benefited from extensive research into nanomaterials, molecular diagnostics, point-of-care testing, and optical biosensing. The presence of specialized biosensor developers and well-established clinical laboratory networks also supported commercialization of quantum dot-based detection platforms. Increasing demand for rapid and sensitive biomarker detection in areas such as cancer diagnostics, infectious diseases, and personalized medicine further strengthened adoption. Strong research collaboration between universities, healthcare institutions, and technology developers continued to support innovation in quantum dot biosensing.

Asia-Pacific is expected to be the fastest-growing region in the Quantum Dot Biosensors Market during the forecast period, driven by expanding healthcare infrastructure, rising biotechnology investment, and increasing demand for advanced diagnostic technologies. China, Japan, South Korea, and India are expected to contribute significantly through growing research in nanotechnology, biosensors, molecular diagnostics, and point-of-care testing. Increasing healthcare expenditure and the need for rapid detection of chronic and infectious diseases are creating opportunities for highly sensitive biosensing platforms. Quantum dot technologies are also being explored for food safety and environmental monitoring, broadening their application base. Expanding research capabilities and local technology development are expected to further accelerate adoption across the region.

Key Trends and Drivers

Multiplexed Fluorescence and Near-Infrared Detection:

A key trend in the quantum dot biosensors market is the development of multiplexed fluorescence and near-infrared sensing platforms capable of detecting several biomarkers simultaneously. Quantum dots offer tunable emission wavelengths, high photostability, and strong fluorescence, allowing different quantum dots to be assigned to different biological targets within the same assay. Near-infrared quantum dots are also gaining attention because they can reduce tissue autofluorescence and improve imaging depth for biological applications. Recent research highlights QD-based platforms for simultaneous detection of proteins, nucleic acids, pathogens, and cancer biomarkers, supporting more comprehensive disease profiling and real-time molecular analysis.

Demand for Highly Sensitive Early Disease Detection:

A key driver of the quantum dot biosensors market is the need to detect low-abundance biomarkers at an early stage of disease. Conventional diagnostic methods can face limitations when biomarkers occur at very low concentrations, particularly during early disease progression. Quantum dots provide high quantum yields, tunable optical properties, and strong photostability, enabling sensitive detection of proteins, nucleic acids, metabolites, and cancer-related biomarkers. Research has demonstrated extremely low detection levels using QD-enhanced sensing platforms, while surface functionalization with antibodies, aptamers, peptides, and nucleic acids improves target specificity. These capabilities are supporting the development of more sensitive, multiplexed, and potentially rapid diagnostic technologies.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Material Type
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Installation Type
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Fluorescent
    • 4.1.2 Electrochemical
    • 4.1.3 Colorimetric
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 In-Vitro Diagnostics
    • 4.2.2 Point-of-Care Testing Devices
    • 4.2.3 Wearable Biosensors
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Quantum Dot Conjugation
    • 4.3.2 Surface Modification
    • 4.3.3 Signal Amplification
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Medical Diagnostics
    • 4.4.2 Environmental Monitoring
    • 4.4.3 Food Safety Testing
    • 4.4.4 Drug Discovery
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Material Type (2020-2035)
    • 4.5.1 Cadmium-Based Quantum Dots
    • 4.5.2 Cadmium-Free Quantum Dots
    • 4.5.3 Carbon Quantum Dots
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Research Laboratories
    • 4.6.3 Pharmaceutical Companies
    • 4.6.4 Biotechnology Firms
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Quantum Dot Core
    • 4.7.2 Surface Coating
    • 4.7.3 Biorecognition Elements
    • 4.7.4 Transducer
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Detection
    • 4.8.2 Quantification
    • 4.8.3 Monitoring
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 Portable
    • 4.9.2 Benchtop
    • 4.9.3 Wearable
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Single-Use
    • 4.10.2 Reusable
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Material Type
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Installation Type
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Material Type
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Installation Type
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Material Type
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Installation Type
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Material Type
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Installation Type
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Material Type
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Installation Type
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Material Type
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Installation Type
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Material Type
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Installation Type
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Material Type
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Installation Type
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Material Type
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Installation Type
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Material Type
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Installation Type
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Material Type
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Installation Type
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Material Type
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Installation Type
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Material Type
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Installation Type
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Material Type
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Installation Type
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Material Type
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Installation Type
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Material Type
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Installation Type
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Material Type
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Installation Type
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Material Type
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Installation Type
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Material Type
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Installation Type
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Material Type
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Installation Type
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Material Type
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Installation Type
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Material Type
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Installation Type
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Material Type
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Installation Type
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Material Type
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Installation Type
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Thermo Fisher Scientific
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Merck Group
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Bio-Rad Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 PerkinElmer
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Danaher Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Horiba
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ocean Insight
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Hamamatsu Photonics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Oxford Instruments
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Bruker Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Hitachi High-Tech
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Zeiss Group
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Shimadzu Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Nikon Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 PicoQuant
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Quantum Materials Corp
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 QD Vision
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Nanoco Group
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Nanosys
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기